Opendata, web and dolomites

GET-UP BAT

GPCR Exploitation To Unlock the Power of Brown/Beige Adipose Tissue

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GET-UP BAT project word cloud

Explore the words cloud of the GET-UP BAT project. It provides you a very rough idea of what is the project "GET-UP BAT" about.

adverse    activation    options    lowered    erc    starting    benefit    longer    scope    compounds    treating    worldwide    protein    tangible    ideally    strengthen    observing    beige    metabolic    receptors    harness    consuming    strategies    holds    gcprs    combination    bat    team    hundreds    ip    burning    gpcr    discovery    performed    coupled    critical    patentable    adipose    desperately    maximize    bodyweight    obese    ipr    treat    poc    obesity    treatment    economic    screen    administration    commercial    functions    tissue    vivo    experts    cardiovascular    diminish    poised    seek    consequently    acrobat    disease    sensitivity    unfortunately    attempts    adrenergic    innovation    assembled    peptide    extend    alternatives    platforms    expectancy    found    therapeutic    linked    analogues    quality    brown    life    glucose    validated    largely    ligand    millions    suffer    diseases    strategy    calorie    vitro    diabetes    combined    mice    consumption    uncovering    position    lived    people    enormous    pharmacology    hindered    class    grant    oxygen    cells    insulin    societal    initial    head    beta   

Project "GET-UP BAT" data sheet

The following table provides information about the project.

Coordinator
KOBENHAVNS UNIVERSITET 

Organization address
address: NORREGADE 10
city: KOBENHAVN
postcode: 1165
website: www.ku.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 149˙986 €
 EC max contribution 149˙986 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-10-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) coordinator 149˙986.00

Map

 Project objective

Hundreds of millions of people suffer from obesity and diabetes worldwide. These diseases diminish both life quality and expectancy and new treatment strategies are desperately needed. One possible approach is to target the calorie-burning and glucose-consuming functions of brown and beige adipose tissue (B/BAT). Previous attempts to harness the therapeutic potential of B/BAT have largely focused on the β-adrenergic class of G protein-coupled receptors (GCPRs). Unfortunately, these methods are hindered by adverse cardiovascular side effects linked to adrenergic activation. Therefore, uncovering non-adrenergic alternatives to exploit B/BAT for treating metabolic disease holds the potential for enormous societal and economic benefit.

Here, we propose the activation of one such non-adrenergic GPCR on B/BAT as a means to treat obesity and diabetes. We identified this GPCR from a screen of B/BAT receptors performed in my ERC Starting Grant project, aCROBAT. We found that treating brown adipose cells with the peptide ligand for this GPCR increased oxygen consumption. We recognized the therapeutic potential after observing that ligand administration in vivo lowered bodyweight and improved insulin sensitivity in obese mice. However, the resources required to develop this discovery into a tangible innovation extend beyond the scope of aCROBAT.

Consequently, I’m applying for an ERC PoC grant for critical support to take the initial steps to commercial application. Specifically, we seek to strengthen our IP position by developing patentable, longer-lived analogues of the ligand. Importantly, we will test these lead compounds head-to-head and in combination with current treatment options. We have assembled a team of experts to address key aspects from peptide design and pharmacology to IPR strategy and commercial development. Combined with our validated in vitro and in vivo testing platforms, we are ideally poised to maximize innovation potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GET-UP BAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GET-UP BAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

RODRESET (2019)

Development of novel optogenetic approaches for improving vision in macular degeneration

Read More